Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB)

111 filings reported holding YMAB - Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2021.
Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 25.7M shares of 45.1M outstanding shares and own 57.06% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4.27M shares), BlackRock Inc. (2.77M shares), Sofinnova Investments, Inc. (2.19M shares), ALLIANCEBERNSTEIN L.P. (1.94M shares), VANGUARD GROUP INC (1.82M shares), Artisan Partners Limited Partnership (1.58M shares), FMR LLC (1.53M shares), STATE STREET CORP (1.46M shares), Polar Capital Holdings Plc (1.38M shares), and GEODE CAPITAL MANAGEMENT, LLC (621K shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.